Your browser doesn't support javascript.
loading
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7.
Takahashi, T; Yamazaki, K; Oki, E; Shiozawa, M; Mitsugi, K; Makiyama, A; Nakamura, M; Ojima, H; Kagawa, Y; Matsuhashi, N; Okuda, H; Asayama, M; Yuasa, Y; Shimada, Y; Manaka, D; Watanabe, J; Oba, K; Yoshino, T; Yoshida, K; Maehara, Y.
  • Takahashi T; Department of Digestive Surgery, Gifu University Hospital, Gifu, Japan. Electronic address: takaota@gifu-u.ac.jp.
  • Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Oki E; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
  • Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Mitsugi K; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan.
  • Makiyama A; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Nakamura M; Department of Gastroenterology, Sapporo City General Hospital, Hokkaido, Japan.
  • Ojima H; Department of Gastroenterological Surgery, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Kagawa Y; Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan.
  • Matsuhashi N; Department of Digestive Surgery, Gifu University Hospital, Gifu, Japan.
  • Okuda H; Department of Medical Oncology, Keiyukai Sapporo Hospital, Hokkaido, Japan.
  • Asayama M; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Yuasa Y; Department of Gastrointestinal Surgery, Tokushima Red Cross Hospital, Tokushima, Japan.
  • Shimada Y; Division of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan.
  • Manaka D; Department of Surgery, Kyoto Katsura Hospital, Kyoto, Japan.
  • Watanabe J; Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan.
  • Oba K; Department of Interfaculty and Initiatives in Information Studies, University of Tokyo, Tokyo, Japan.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Yoshida K; Department of Digestive Surgery, Gifu University Hospital, Gifu, Japan.
  • Maehara Y; Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
ESMO Open ; 6(2): 100093, 2021 04.
Article en En | MEDLINE | ID: mdl-33744811
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article